Trials / Completed
CompletedNCT05051943
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
A Prospective Observational Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 754 (actual)
- Sponsor
- Fresenius Kabi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to describe the real-world profile of patients treated with adalimumab FK in gastroenterology, dermatology or rheumatology in order to evaluate in this population the predictive factors of therapeutic response (in particular nutritional status) and generate hypothesis between nutritional status and therapeutic response.
Conditions
- Crohn Disease
- Ulcerative Colitis
- Psoriasis
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Psoriatic Arthritis
Timeline
- Start date
- 2020-09-29
- Primary completion
- 2023-01-20
- Completion
- 2023-01-20
- First posted
- 2021-09-21
- Last updated
- 2023-07-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05051943. Inclusion in this directory is not an endorsement.